v3.22.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Class A and Class B Common Stock, Class C Capital Stock and Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning Balance (in shares) at Dec. 31, 2018     695,556        
Beginning Balance at Dec. 31, 2018 $ 177,628 $ (34) $ 45,049 $ (2,306) $ (30) $ 134,885 $ (4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common and capital stock issued (in shares)     8,120        
Common and capital stock issued 202   $ 202        
Stock-based compensation expense 10,890   10,890        
Income tax withholding related to vesting of restricted stock units and other (4,455)   $ (4,455)        
Repurchases of capital stock (in shares)     (15,341)        
Repurchases of capital stock (18,396)   $ (1,294)     (17,102)  
Sale of interest in consolidated entities 160   $ 160        
Net income 34,343         34,343  
Other comprehensive income (loss) 1,104     1,104      
Ending Balance (in shares) at Dec. 31, 2019     688,335        
Ending Balance at Dec. 31, 2019 201,442   $ 50,552 (1,232)   152,122  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common and capital stock issued (in shares)     8,398        
Common and capital stock issued 168   $ 168        
Stock-based compensation expense 13,123   13,123        
Income tax withholding related to vesting of restricted stock units and other (5,969)   $ (5,969)        
Repurchases of capital stock (in shares)     (21,511)        
Repurchases of capital stock (31,149)   $ (2,159)     (28,990)  
Sale of interest in consolidated entities 2,795   $ 2,795        
Net income 40,269         40,269  
Other comprehensive income (loss) 1,865     1,865      
Ending Balance (in shares) at Dec. 31, 2020     675,222        
Ending Balance at Dec. 31, 2020 222,544   $ 58,510 633   163,401  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Common and capital stock issued (in shares)     7,225        
Common and capital stock issued 12   $ 12        
Stock-based compensation expense 15,539   15,539        
Income tax withholding related to vesting of restricted stock units and other (10,273)   $ (10,273)        
Repurchases of capital stock (in shares)     (20,326)        
Repurchases of capital stock (50,274)   $ (2,324)     (47,950)  
Sale of interest in consolidated entities 310   $ 310        
Net income 76,033         76,033  
Other comprehensive income (loss) (2,256)     (2,256)      
Ending Balance (in shares) at Dec. 31, 2021     662,121        
Ending Balance at Dec. 31, 2021 $ 251,635   $ 61,774 $ (1,623)   $ 191,484